BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24780897)

  • 21. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.
    Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M
    Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging.
    Herth MM; Hansen HD; Ettrup A; Dyssegaard A; Lehel S; Kristensen J; Knudsen GM
    Bioorg Med Chem; 2012 Jul; 20(14):4574-81. PubMed ID: 22682922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.
    Andersen VL; Hansen HD; Herth MM; Dyssegaard A; Knudsen GM; Kristensen JL
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1053-6. PubMed ID: 25655720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
    Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression.
    Visser AK; Ettrup A; Klein AB; van Waarde A; Bosker FJ; Meerlo P; Knudsen GM; de Boer SF
    Synapse; 2015 Apr; 69(4):226-32. PubMed ID: 25684736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain.
    Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Bundgaard C; Bang-Andersen B; Sanchez C; Halldin C; Farde L; Finnema SJ
    Neuropsychopharmacology; 2019 Sep; 44(10):1706-1713. PubMed ID: 31216565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
    Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT
    Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM
    J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET).
    Hodé Y; Benyamina A; Arbus C; Reimold M
    Psychopharmacology (Berl); 2011 Oct; 217(3):315-21. PubMed ID: 21479533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the serotonin 2A receptor selective PET tracer (R)-[
    Kramer V; Dyssegaard A; Flores J; Soza-Ried C; Rösch F; Knudsen GM; Amaral H; Herth MM
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):355-365. PubMed ID: 31606832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
    Catafau AM; Searle GE; Bullich S; Gunn RN; Rabiner EA; Herance R; Radua J; Farre M; Laruelle M
    J Cereb Blood Flow Metab; 2010 May; 30(5):985-93. PubMed ID: 20029452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
    Meyer PT; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM; Hinz R
    Neuroimage; 2010 Apr; 50(3):984-93. PubMed ID: 20083209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.
    Catafau AM; Danus M; Bullich S; Nucci G; Llop J; Abanades S; Cunningham VJ; Eersels JL; Pavia J; Farre M
    J Nucl Med; 2006 Jun; 47(6):929-37. PubMed ID: 16741301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.
    Bhagwagar Z; Hinz R; Taylor M; Fancy S; Cowen P; Grasby P
    Am J Psychiatry; 2006 Sep; 163(9):1580-7. PubMed ID: 16946184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.